1 – 10 of 24
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2018
-
Mark
Paquinimod prevents development of diabetes in the non-obese diabetic (NOD) mouse
(
- Contribution to journal › Article
-
Mark
Induction of S100A9 homodimer formation in vivo
(
- Contribution to journal › Article
- 2017
-
Mark
Pro-inflammatory S100 proteins are associated with glomerulonephritis and anti-dsDNA antibodies in systemic lupus erythematosus
(
- Contribution to journal › Article
- 2016
-
Mark
Platelet-derived S100A8/A9 and cardiovascular disease in systemic lupus erythematosus.
2016) In Arthritis & Rheumatology(
- Contribution to journal › Article
-
Mark
CD14 is a co-receptor for TLR4 in the S100A9-induced pro-inflammatory response in monocytes
(
- Contribution to journal › Article
-
Mark
The anti-tumor effect of the quinoline-3-carboxamide tasquinimod : Blockade of recruitment of CD11b+ Ly6Chi cells to tumor tissue reduces tumor growth
(
- Contribution to journal › Article
- 2015
-
Mark
Vesicular Location and Transport of S100A8 and S100A9 Proteins in Monocytoid Cells.
(
- Contribution to journal › Article
-
Mark
S100A9 as a pharmacological target molecule in inflammation and cancer.
(
- Contribution to journal › Article
- 2014
-
Mark
The quinoline-3-carboxamide paquinimod (ABR-215757) reduces leukocyte recruitment during sterile inflammation: Leukocyte- and context-specific effects.
(
- Contribution to journal › Article
-
Mark
Quinoline-3-carboxamides modulate primary T cell-dependent B cell responses but do not inhibit functional immunity.
(
- Contribution to journal › Article